InsidersTradesSigma
Explore the complete record of transactions filed by GREATHOUSE KENNETH, Dirigeant. Insider active across 1 companies, notably Zosano Pharma Corp. In total, 6 filings have been published. Total volume traded: €11k. The latest transaction was disclosed on 23 November 2021 — Cession. Regulator: SEC (Form 4). The full history is accessible without signup.
6 of 6 declarations
Kenneth Greathouse is a Director at Zosano Pharma Corp, a biopharmaceutical company. In this role, he contributes to the governance and strategy of the company, which focuses on developing innovative treatments. Greathouse plays a key role in Zosano's strategic direction.